Franklin Resources’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.14M Buy
+230,578
New +$3.22M ﹤0.01% 1703
2026
Q1
Sell
-19,256
Closed -$239K 3227
2025
Q4
$239K Buy
19,256
+5,720
+42% +$76K ﹤0.01% 2712
2025
Q3
$194K Sell
13,536
-250
-2% -$3.42K ﹤0.01% 2844
2025
Q2
$169K Sell
13,786
-66
-0.5% -$958 ﹤0.01% 2787
2025
Q1
$305K Buy
+13,852
New +$326K ﹤0.01% 2482
2024
Q3
Sell
-16,556
Closed -$482K 2964
2024
Q2
$482K Buy
16,556
+3,581
+28% +$106K ﹤0.01% 2243
2024
Q1
$460K Buy
12,975
+1,540
+13% +$61.6K ﹤0.01% 2294
2023
Q4
$498K Buy
11,435
+5,009
+78% +$197K ﹤0.01% 1945
2023
Q3
$245K Sell
6,426
-4
-0.1% -$168 ﹤0.01% 2241
2023
Q2
$264K Buy
+6,430
New +$309K ﹤0.01% 2266
2022
Q4
Sell
-279,412
Closed -$11.8M 2359
2022
Q3
$11.8M Buy
279,412
+79,941
+40% +$4.1M 0.01% 888
2022
Q2
$10.8M Buy
+199,471
New +$12M 0.01% 938

Other funds holding IART

Franklin Resources's IART Position: Q2 2026 in Review

Franklin Resources opened a new position in Integra LifeSciences (IART) in Q2 2026: 230,578 shares worth $4.14M. The stake represents ﹤0.01% of the portfolio and ranks #1703 among its holdings. This is a return to the name: Franklin Resources previously reported a position in IART as recently as Q4 2025.

Franklin Resources first reported a position in IART in Q2 2022 and has held it in 12 quarters since. The position peaked at $11.8M in Q3 2022. 213 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Franklin Resources held 230,578 shares of Integra LifeSciences worth $4.14M as of Q2 2026.
  • Integra LifeSciences was a new Franklin Resources position in Q2 2026.
  • Integra LifeSciences made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #1703 holding.
  • Franklin Resources first reported a position in Integra LifeSciences in Q2 2022 and has held it in 12 quarters since.
  • Franklin Resources's Integra LifeSciences position peaked at $11.8M in Q3 2022.
  • 213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.